Orion Pharma Limited (DSE:ORIONPHARM)

Market Cap	5.90B -20.8%
Revenue (ttm)	3.01B -51.4%
Net Income	-595.30M
EPS	-2.54
Shares Out	234.00M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,251,762
Open	n/a
Previous Close	26.30
Day's Range	24.90 - 27.00
52-Week Range	22.90 - 33.20
Beta	-0.44
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 12, 2026

About Orion Pharma

Orion Pharma Limited engages in the creation, discovery, development, manufacturing, and marketing of pharmaceutical products in Bangladesh. It produces products in various dosage forms, including tablets, capsules, syrups, suspensions, injections, and dry powder for syrup/ suspension in various therapeutic groups, such as anticancer, antibiotics, anti-diabetics, anxiolytics, diuretics, cardiovascular drugs, etc. The company also provides various vaccines and health-related consumer products, as well as generates and supplies electricity. The c...

• Industry: Pharmaceutical Preparations
• Founded: 1965
• Employees: 2,954
• Stock Exchange: Dhaka Stock Exchange
• Ticker Symbol: ORIONPHARM

Financial Performance

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Nov 4, 2026

Data Sources Report a data error